Mediwound announces u.s. fda acceptance of biologics license application for nexobrid for the treatment of severe thermal burns

Prescription drug user fee act (pdufa) target date of january 1, 2023 prescription drug user fee act (pdufa) target date of january 1, 2023

MDWD Ratings Summary

MDWD Quant Ranking